The global pharmaceutical fine chemicals market size reached US$ 141.1 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 233.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.78% during 2023-2032.
Fine chemicals refer to a set of pure and complex chemicals that are manufactured in limited quantities at higher prices. They are produced in multipurpose plants with the support of a multistep batch biotechnological method. Unlike specialty chemicals, these substances are accumulated precisely based on their distinct functional characteristics and specific molecular properties. After collection, fine chemicals are used as key agents, stabilizers, and solvents for producing several pharmaceutical chemical products, including magnesium stearate and gelatin. At present, they are commercially available in proprietary and non-proprietary variants.
Additionally, enforcement of different guidelines for utilizing pharmaceutical fine chemicals as raw materials to manufacture medicines, while meeting the quality standards is contributing to the market growth. Other factors, such as significant expansion in the pharmaceutical industry, increasing investments in the research and development (R&D) activities, and the growing consumer awareness regarding numerous disorders and the available medication options, are creating a positive outlook for the market across the globe.
2. What is the expected growth rate of the global pharmaceutical fine chemicals market during 2024-2032?
3. What are the key factors driving the global pharmaceutical fine chemicals market?
4. What has been the impact of COVID-19 on the global pharmaceutical fine chemicals market?
5. What is the breakup of the global pharmaceutical fine chemicals market based on the type?
6. What is the breakup of the global pharmaceutical fine chemicals market based on the product?
7. What is the breakup of the global pharmaceutical fine chemicals market based on the size?
8. What are the key regions in the global pharmaceutical fine chemicals market?
9. Who are the key players/companies in the global pharmaceutical fine chemicals market?
Fine chemicals refer to a set of pure and complex chemicals that are manufactured in limited quantities at higher prices. They are produced in multipurpose plants with the support of a multistep batch biotechnological method. Unlike specialty chemicals, these substances are accumulated precisely based on their distinct functional characteristics and specific molecular properties. After collection, fine chemicals are used as key agents, stabilizers, and solvents for producing several pharmaceutical chemical products, including magnesium stearate and gelatin. At present, they are commercially available in proprietary and non-proprietary variants.
Pharmaceutical Fine Chemicals Market Trends:
The increasing prevalence of various neurological and cardiovascular diseases, including arrhythmias, stroke, cancer, and coronary artery ailments, especially amongst the geriatric population, is one of the prime factors driving the pharmaceutical fine chemical market toward growth. In line with this, favorable initiatives undertaken by the government bodies of several nations for introducing novel vaccines, drugs, and pharmaceutical medications for retaliating against coronavirus diseases (COVID-19) and several other disorders is further facilitating the widespread adoption of these medications in the healthcare sector. This, in turn, is acting as another growth-inducing factor in the market.Additionally, enforcement of different guidelines for utilizing pharmaceutical fine chemicals as raw materials to manufacture medicines, while meeting the quality standards is contributing to the market growth. Other factors, such as significant expansion in the pharmaceutical industry, increasing investments in the research and development (R&D) activities, and the growing consumer awareness regarding numerous disorders and the available medication options, are creating a positive outlook for the market across the globe.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global pharmaceutical fine chemicals market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, product, size and application.Breakup by Type:
- Proprietary
- Non-proprietary
Breakup by Product:
- Active Ingredients
- Basic Building Blocks
- Advanced Intermediates
Breakup by Size:
- Big Molecules
- Small Molecules
Breakup by Application:
- Cardiovascular
- Neurological
- Oncological
- Respiratory
- Gastrointestinal
- Musculoskeletal
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Borregaard ASA, CHEMADA Industries Ltd. (Turpaz), Denisco Chemicals Pvt Ltd, Dupont De Nemours Inc., Eastman Chemical Company, Evonik Industries AG, Koninklijke DSM N.V., Lonza Group AG, Solvay S.A., Syntor Fine Chemicals Ltd. (Aceto Corporation) and W. R. Grace and Co. (Standard Industries Inc.).Key Questions Answered in This Report
1. How big is the global pharmaceutical fine chemicals market?2. What is the expected growth rate of the global pharmaceutical fine chemicals market during 2024-2032?
3. What are the key factors driving the global pharmaceutical fine chemicals market?
4. What has been the impact of COVID-19 on the global pharmaceutical fine chemicals market?
5. What is the breakup of the global pharmaceutical fine chemicals market based on the type?
6. What is the breakup of the global pharmaceutical fine chemicals market based on the product?
7. What is the breakup of the global pharmaceutical fine chemicals market based on the size?
8. What are the key regions in the global pharmaceutical fine chemicals market?
9. Who are the key players/companies in the global pharmaceutical fine chemicals market?
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis14 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Pharmaceutical Fine Chemicals Market
6 Market Breakup by Type
7 Market Breakup by Product
8 Market Breakup by Size
9 Market Breakup by Application
10 Market Breakup by Region
11 SWOT Analysis
13 Porters Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- BASF SE
- Borregaard ASA
- CHEMADA Industries Ltd. (Turpaz)
- Denisco Chemicals Pvt Ltd
- Dupont De Nemours Inc.
- Eastman Chemical Company
- Evonik Industries AG
- Koninklijke DSM N.V.
- Lonza Group AG
- Solvay S.A.
- Syntor Fine Chemicals Ltd. (Aceto Corporation)
- W. R. Grace
- Co. (Standard Industries Inc.)
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 141 |
| Published | August 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 141.1 Billion |
| Forecasted Market Value ( USD | $ 233.9 Billion |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
